Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Scholars @ UT Health San Antonio Inicio
Ayuda y preguntas frecuentes
English
Español
Inicio
Perfiles
Unidades de investigación
Resultados de investigaciones
Buscar por experiencia, nombre o afiliación
Antiretroviral agents
Christine J. Kubin,
Barbara S. Taylor
, Scott M. Hammer
Department of Medicine
Resultado de la investigación
:
Chapter
1
Cita (Scopus)
Información general
Huella
Huella
Profundice en los temas de investigación de 'Antiretroviral agents'. En conjunto forman una huella única.
Clasificar por
Ponderación
Alfabéticamente
Medicine and Dentistry
Antiretrovirus Agent
25%
Chemokine
25%
Chemotherapeutic Agent
50%
Combination Therapy
25%
Diseases
25%
Drug
50%
Drug Resistance
25%
Enhancer Region
25%
Exercise
25%
Fusion Inhibitor
100%
Human Immunodeficiency Virus 1
50%
Infection
25%
Integrase
25%
Monitoring
25%
Nonnucleoside Reverse Transcriptase Inhibitor
25%
Nucleoside
25%
Nucleotide
25%
Pathogenesis
25%
Pharmacokinetics
25%
Plasma
25%
Proteinase Inhibitor
25%
Reverse-Transcriptase Inhibitor
25%
RNA
25%
Target Cell
25%
Therapeutic Procedure
25%
Virion
25%
Virus Replication
25%
Zidovudine
25%
Chemistry
Antagonist
75%
Antiretrovirus Agent
25%
Chemokine
25%
Concentration
25%
Drug Target
25%
Enhancer
25%
Inhibitor
100%
Integrase Inhibitor
25%
Nonnucleoside Reverse Transcriptase Inhibitor
25%
Nucleoside
25%
Nucleotide
25%
Pharmacokinetics
25%
Procedure
25%
Resistance
25%
RNA
25%
Zidovudine
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antiretrovirus Agent
25%
Diseases
25%
Drug
50%
Drug Development
25%
Drug Resistance
25%
Human Immunodeficiency Virus 1
50%
Human Immunodeficiency Virus Fusion Inhibitor
25%
Infection
25%
Integrase
25%
Nonnucleoside Reverse Transcriptase Inhibitor
25%
Nucleoside
25%
Pathogenesis
25%
Pharmacokinetics
25%
Proteinase Inhibitor
25%
RNA
25%
Zidovudine
25%
Biochemistry, Genetics and Molecular Biology
CD4
25%
Chemokine
25%
Drug Resistance
25%
Enhancer Region
25%
Exercise
25%
Human Immunodeficiency Virus 1
50%
Integrase
25%
Nucleoside
25%
Pharmacokinetics
25%
Process Development
25%
Target Cell
25%
Virion
25%
Virus Replication
25%
Zidovudine
25%
Neuroscience
CD4
25%
Chemokine
25%
Drug Resistance
25%
Enhancer Region
25%
Entry Inhibitor
50%
Integrase
25%
Non-Nucleoside Reverse Transcriptase Inhibitors
25%
Nucleoside
25%
Pharmacokinetics
25%
Reverse Transcriptase Inhibitors
25%
RNA
25%
Zidovudine
25%